Stéphane Carlier, MD, PhD is a practicing medical doctor and bioengineer. He is currently interventional cardiologist at the University Hospital Ambroise Paré in Mons (Belgium), and professor of Cardiology and director of the Department of Cardiology at University of Mons (UMONS). He held previously the position of Assistant Professor of Clinical Medicine and Bioengineering at the Columbia University in New York and Director of the Intravascular Imaging & Physiology Corelab of the Cardiovascular Research Foundation. He is advisor and consultant for different biomedical companies. He is a member of several reviewing boards of medical and bioengineering journals.
His research interests include new intravascular and X-ray imaging, cardiac and vascular dynamics, physiology and signal processing with a high-volume scientific output.
Expert in clinical research, he led a corelab in New York that analyzed important interventional cardiology trials using intravascular imaging (IVUS). This knowledge has been translated to UMONS, in the new corelab of the department of Cardiology where analysis for multicenter studies are performed, or the design of new trials implemented for biomedical companies. In parallel, more fundamental research is performed on atherosclerosis in mice, with a focus on non-invasive detection of plaques using NMR probes targeted to VCAM.
Stéphane Carlier, MD, PhD is a practicing medical doctor and bioengineer. He is currently interventional cardiologist at the University Hospital Ambroise Paré in Mons (Belgium), and professor of Cardiology and director of the Department of Cardiology at University of Mons (UMONS). He held previously the position of Assistant Professor of Clinical Medicine and Bioengineering at the Columbia University in New York and Director of the Intravascular Imaging & Physiology Corelab of the Cardiovascular Research Foundation. He is advisor and consultant for different biomedical companies. He is a member of several reviewing boards of medical and bioengineering journals.
His research interests include new intravascular and X-ray imaging, cardiac and vascular dynamics, physiology and signal processing with a high-volume scientific output.
Expert in clinical research, he led a corelab in New York that analyzed important interventional cardiology trials using intravascular imaging (IVUS). This knowledge has been translated to UMONS, in the new corelab of the department of Cardiology where analysis for multicenter studies are performed, or the design of new trials implemented for biomedical companies. In parallel, more fundamental research is performed on atherosclerosis in mice, with a focus on non-invasive detection of plaques using NMR probes targeted to VCAM.